Navigation Links
SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China
Date:3/17/2011

WASHINGTON, LONDON and HONG KONG, March 17, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology Co., Ltd. ("KSB"), a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets.  Financial terms of the agreement were not disclosed.

"We are delighted to announce this agreement with KSB Diagnostics, a leader in China and Asia for diagnostics," said Neil Campbell, president & CEO of SuperNova Diagnostics.  "This collaborative relationship allows SuperNova and KSB to expand R&D, manufacturing and commercialisation into one of the world's largest markets."

About AmpCrystal® TechnologyAmpCrystal®, SuperNova Diagnostics' lead technology with multiple product formats, allows for minimally trained individuals (advanced CLIA-waived) to test for a wide range of protein analytes and can detect directly un-amplified DNA in humans, animals or environmental samples. AmpCrystal® is hyper-dense, energy-mediated proprietary nanocrystals that can be utilised in a wide variety of diagnostic applications and configurations. The technology platform lends itself to both forward-integration into new product formats as well as backward compatible into existing open and closed diagnostic systems.

Time-to-result has been shown in prototypes to be reduced to minutes on the spot versus the hours or days required when sending samples to a central laboratory or processing in regional satellite laboratories.  With three integrated capabilities (sample collector/processor, analytical disposable, and the readout device), the technology is simpler, more robust, faster and significantly less expensive than existing POC systems.

About Shenzhen Kang Sheng Bao Bio-Technology Co. Ltd "KSB"KSB provides innovative diagnostic kits and technologies to serve the large developing market in China and is a leader in vitro diagnostic reagents, OEM manufacture and contractual R&D and through partnerships possesses products with international brand (such as drugs, medical devices, bio-products, diagnostic kits, scientific research instruments, etc.), and has business relations with more than 30 countries and regions.

For additional information, please visit www.ksbbiotech.com/en/index.html

About SuperNova Diagnostics®, Inc.SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® - Putting the Laboratory in the Palm of Your Hand®.

For additional information, please visit www.supernovadiagnostics.com.Media Contacts:Tiberend Strategic Advisors, Inc.(212) 827-0020Farrell Denby, fdenby@tiberend.comorTamara Bright, tbright@tiberend.com
'/>"/>

SOURCE SuperNova Diagnostics®, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13
2. Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S.
3. ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®s Label Claim
4. Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
5. China Nepstar Chain Drugstore Announces Management Appointments
6. Nephros Announces Split Adjusted Trade Date
7. Bionovo Announces 2010 Highlights and Year-End Financial Results
8. Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors
9. The Electro-Nail - Better Design for Faster Healing. ICAP Ocean Tomo Announces Auction of an Advanced Electro-Nail Implant System for Electro-Magnetic Bone Stimulation in Orthopedics
10. Healthier Healing for Hip Resurfacing - ICAP Ocean Tomo Announces Auction of an Advanced Hip Cap for Electromagnetic Tissue Stimulation by Neue Magnetodyn.
11. LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb.11, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ... on Thursday, February 25 at 11:30 a.m. Eastern Time to ... business progress. www.ionispharma.com . A webcast replay ... address. --> www.ionispharma.com . A webcast replay will ... --> Interested parties may listen to the call ...
(Date:2/11/2016)... , Feb. 11, 2016  Galmed Pharmaceuticals Ltd. (Nasdaq: ... on the development of a once-daily, oral therapy for ... Chief Medical Officer, Dr. Maya Halpern , has notified ... Chief Medical Officer and from its Board of Directors ... reaching retirement age. Allen Baharaff . Mr. ...
(Date:2/11/2016)... 2016 North America , ... MarketsandMarkets, The global market is expected to reach USD 20,190.1 Million ... CAGR of 10.2%. --> North America , ... by MarketsandMarkets, The global market is expected to reach USD 20,190.1 ... a CAGR of 10.2%. --> According to a new ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Life is known for throwing curves. ... and older, who gather once a year to play softball to raise money through ... game, the more than 50 players who competed in this year’s softball tournament share ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... and updated its hallmark resource, Infusion Therapy Standards of Practice, to include vascular ... vein illumination with an estimated 85% share of the market, facilitates adherence to ...
(Date:2/11/2016)... ... February 11, 2016 , ... Dickinson Insurance & Financial Services ... a new fundraiser in support of a local boy named Barrett, who has been ... bring awareness to, and rally support for, all local families dealing with childhood cancer. ...
(Date:2/11/2016)... VA (PRWEB) , ... February 11, 2016 , ... ... its new office in the heart of Old Town at 108 South Columbus St, ... and businesses the highest level of medical care in the convenience of their homes, ...
(Date:2/11/2016)... ... , ... Husted Kicking has completed its Third Annual Husted Kicking ... 7th, 2016 according to kicking coach Michael Husted. , “This event serves as an ... in Indianapolis,” says Husted. “The NFL uses a third party organization to select players ...
Breaking Medicine News(10 mins):